Sandra Sanguino, ’93 MD, MPH, associate dean for Student Affairs, has received the Exceptional Mentor Award from the American Medical Women’s Association.
Year: 2017
A phase 1 clinical trial of venetoclax and rituximab combination therapy was shown to be an effective chemo-free treatment option for patients with difficult-to-treat chronic lymphocytic leukemia.
A newly identified biomarker may predict treatment response in patients with chronic myelogenous leukemia, according to a Northwestern Medicine study.
Nearly 300 principal investigators gathered for a day of discussion and brainstorming to generate transformative ideas that will help guide the Feinberg research enterprise for the next five years.
As part of their community health project, first-year medical students presented on the barriers populations in different Chicago neighborhoods face to lead healthy lives.
Northwestern Medicine scientists identified the process by which a calcium channel called the CRAC channel opens and closes, and how mutations in the channel structures that control its opening cause disease.
In recent Northwestern Medicine clinical trials, an experimental drug improved survival rates for patients with advanced midgut neuroendocrine tumors compared to a standard therapy.
A paper published in Molecular Cell provides new insight into a protein complex called COMPASS and its function during histone methylation, a key modification that regulates gene expression.
Northwestern housestaff took part in the first McGaw Resident and Fellow Wellness Week, aimed at addressing burnout and providing strategies to improve wellness.
Melissa Simon, MD, the George H. Gardner Professor of Clinical Gynecology, has been appointed to the U.S. Preventive Services Task Force, which makes evidence-based recommendations for preventive screenings, counseling services and medications.